A Texas medical cannabis provider has released the results of a post-traumatic stress disorder (PTSD) focus group.
Manchaca-based Texas Original Compassionate Cultivation (TXOG) on Tuesday announced the results of the focus group, showing the positive effects of medical cannabis use in patients with PTSD.
TXOG says the focus group included veterans with PTSD who use medical cannabis under the expanded Compassionate Use Program.
According to TXOG, 100 percent of the focus group participants indicated that they experienced PTSD symptom relief while using the company’s products.
TXOG says the response mirrors recent peer-reviewed studies from Wayne State University and the Federal University of Paraná indicating lower threat-related amygdala reactivity and suppressed anxiety in PTSD patients using medical cannabis.
TXOG CEO Morris Denton says many veterans in Texas and the rest of the United States face a much different enemy when they return home, one that is invisible but no less dangerous.
“Medical cannabis plays a critical role in many of those veterans’ lives,” says Denton. “TXOG stands committed to being an ally in that fight by doing whatever we can to not only help them find symptom relief, but to continue to drive the expansion of medical cannabis legislation that enhances accessibility for more veterans and other Texans suffering from PTSD.”
Focus Group Results
According to TXOG, qualified focus group participants used its gummy, lozenge, and tincture products at doses prescribed by their physicians and overwhelmingly experienced a quick product onset.
TXOG says 77 percent of participants experienced a 30 minute onset time for gummies, as did 62 percent of tincture users.
Overall, 85 percent of participants responded that they were mostly or very satisfied with product onset time, and more than 60 percent indicated a preference for TXOG’s gummy products.
TXOG gummy products come in 0:1 THC-only and 1:1 THC-to-CBD formulations.
TXOG says participants unanimously said they reduced their supplemental medication consumption after using its medical cannabis products.
According to TXOG, all patients reported some level of reduction, with more than 30 percent eliminating additional medications or pharmaceutical products from their treatment plans.
One study participant said their physician had previously prescribed them high doses of clonazepam, making them a zombie.
“Once I found out that PTSD was added as a qualifying condition under the Compassionate Use Program, I met with a doctor and contacted Texas Original,” says the participant. “This medicine has absolutely changed my life. Before incorporating medical cannabis into my treatment plan, I was afraid to leave my home. This medicine gives me the confidence to go out in public and interact with people. During and following the study, I even started going fishing and hiking more!”
People seeking TXOG products can acquire them via the company website, at their dispensary in Austin, and at pick-up locations in North Austin, Addison, Dallas, Fort Worth, Houston, San Antonio, and Wichita Falls.
